TNFAIP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.214200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.227200E-01
Normal-vs-Stage2
3.651800E-01
Normal-vs-Stage3
2.242400E-01
Normal-vs-Stage4
5.523400E-01
Stage1-vs-Stage2
5.393800E-01
Stage1-vs-Stage3
9.196200E-01
Stage1-vs-Stage4
3.935000E-01
Stage2-vs-Stage3
5.404000E-01
Stage2-vs-Stage4
7.094000E-01
Stage3-vs-Stage4
3.553400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.130200E-01
Normal-vs-AfricanAmerican
4.408000E-01
Normal-vs-Asian
2.262200E-01
Caucasian-vs-AfricanAmerican
6.887200E-01
Caucasian-vs-Asian
3.705200E-01
AfricanAmerican-vs-Asian
3.794400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.853650E-01
Normal-vs-Female
5.370000E-01
Male-vs-Female
1.403920E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.937400E-01
Normal-vs-Age(41-60Yrs)
5.505000E-01
Normal-vs-Age(61-80Yrs)
2.967000E-01
Normal-vs-Age(81-100Yrs)
3.633800E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.555400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.222600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.726200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.370500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.620400E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.941360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.807800E-02
Normal-vs-Daily Drinker
7.346400E-02
Normal-vs-Weekly Drinker
3.994000E-01
Normal-vs-Occasional Drinker
3.909400E-01
Normal-vs-Social Drinker
8.546200E-01
Non Drinker-vs-Daily Drinker
9.502400E-01
Non Drinker-vs-Weekly Drinker
1.671420E-01
Non Drinker-vs-Occasional Drinker
5.665800E-02
Non Drinker-vs-Social Drinker
4.759700E-03
Daily Drinker-vs-Weekly Drinker
2.063200E-01
Daily Drinker-vs-Occasional Drinker
7.800000E-02
Daily Drinker-vs-Social Drinker
8.644400E-03
Weekly Drinker-vs-Occasional Drinker
8.021000E-01
Weekly Drinker-vs-Social Drinker
2.550800E-01
Occasional Drinker-vs-Social Drinker
2.833000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.438400E-02
Normal-vs-Grade 2
2.097600E-02
Normal-vs-Grade 3
1.023800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.929800E-02
Grade 1-vs-Grade 3
1.716200E-01
Grade 1-vs-Grade 4
7.438400E-02
Grade 2-vs-Grade 3
6.747400E-01
Grade 2-vs-Grade 4
2.097600E-02
Grade 3-vs-Grade 4
1.023800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.659200E-01
Normal-vs-NonDiabetic
3.839600E-01
Diabetic-vs-NonDiabetic
1.396570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.254200E-01
Normal-vs-NoPancreatitis
2.245000E-01
Pancreatitis-vs-NoPancreatitis
2.258200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.582620E-01
Normal-vs-N1
4.030800E-01
N0-vs-N1
1.764370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.294000E-01
Normal-vs-TP53-NonMutant
1.261620E-01
TP53-Mutant-vs-TP53-NonMutant
2.987800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
